GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Hero Technologies Inc (OTCPK:HENC) » Definitions » 5-Year RORE %

Hero Technologies (Hero Technologies) 5-Year RORE % : 0.00% (As of Sep. 2023)


View and export this data going back to 2006. Start your Free Trial

What is Hero Technologies 5-Year RORE %?

Return on Retained Earnings (RORE) is an indicator of a company's growth potential, it shows how much a company earns by reinvesting its retained earnings, i.e. profits after dividend payments. Hero Technologies's 5-Year RORE % for the quarter that ended in Sep. 2023 was 0.00%.

The industry rank for Hero Technologies's 5-Year RORE % or its related term are showing as below:

HENC's 5-Year RORE % is not ranked *
in the Drug Manufacturers industry.
Industry Median: 2.965
* Ranked among companies with meaningful 5-Year RORE % only.

Hero Technologies 5-Year RORE % Historical Data

The historical data trend for Hero Technologies's 5-Year RORE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hero Technologies 5-Year RORE % Chart

Hero Technologies Annual Data
Trend Dec10 Dec11 Dec12 Dec13 Dec14 Dec15 Dec16 Dec20 Dec21 Dec22
5-Year RORE %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 19.23 - - - -

Hero Technologies Quarterly Data
Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Mar18 Jun18 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
5-Year RORE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Hero Technologies's 5-Year RORE %

For the Drug Manufacturers - Specialty & Generic subindustry, Hero Technologies's 5-Year RORE %, along with its competitors' market caps and 5-Year RORE % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Hero Technologies's 5-Year RORE % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Hero Technologies's 5-Year RORE % distribution charts can be found below:

* The bar in red indicates where Hero Technologies's 5-Year RORE % falls into.



Hero Technologies 5-Year RORE % Calculation

Hero Technologies's 5-Year RORE % for the quarter that ended in Sep. 2023 is calculated as:

5-Year RORE %=( Most Recent EPS (Diluted)- First Period EPS (Diluted) )/( Cumulative EPS (Diluted) for 5-year -Cumulative Dividends per Share for 5-year )
=( - )/( -0.016-0 )
=/-0.016
=0.00 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of 5-Year RORE %, the most recent and first period EPS (Diluted) is the trailing twelve months (TTM) data ended in Sep. 2023 and 5-year before.


Hero Technologies  (OTCPK:HENC) 5-Year RORE % Explanation

Return on Retained Earnings (RORE) is important to investors because it reveals a company's efficiency and growth potential. A higher RORE indicates a higher return. A high RORE indicates that the company should reinvest profits into the business. A lower RORE suggests that the company should distribute profits to shareholders by paying out dividends, since those dollars aren't generating much additional growth for the company.

There are a several different ways to arrive at the Return on Retained Earnings. The simplest way to calculate it is by using published information on Earnings per Share (EPS) and Dividend per Share (DPS) over a selected period. Here, 5-year period is chosen.

Be Aware

Please keep in mind that the RORE is relative to the nature of the business and its competitors. If another company in the same sector is producing a lower return on retained earnings, it doesn’t necessarily mean it’s a bad investment. It may just suggest the company is older and no longer in a high growth stage. At such a stage in the business cycle, it would be expected to see a lower RORE and higher dividend payout.


Hero Technologies 5-Year RORE % Related Terms

Thank you for viewing the detailed overview of Hero Technologies's 5-Year RORE % provided by GuruFocus.com. Please click on the following links to see related term pages.


Hero Technologies (Hero Technologies) Business Description

Traded in Other Exchanges
N/A
Address
8 The Green, Suite 4000, Dover, DE, USA, 19901
Hero Technologies Inc is a cannabis company with a vertically integrated business model and plan that includes cannabis genetic engineering, farmland for medical and recreational cannabis cultivation, production licenses, distribution licenses, consumer packaging, retail operations, and dispensaries. It focuses on two principal segments of the cannabis industry, cultivation, and the dispensary business model, including combinations.
Executives
Gina L. Serkasevich officer: CFO and Treasurer 310 COMMONS TRAIL LANE, HUFFMAN TX 77336
Keith Elliott Macdonald director 203 HERITAGE PLAVE, CALGARY A0 T3Z 3P3
K James Ebeling director 3726 WICKERSHAM LANE, HOUSTON TX 77027
James Douglas Brown director, 10 percent owner, officer: Secretary 11200 WESTHEIMER, SUITE 200, HOUSTON TX 77042
Holloman Value Holdings, Llc 10 percent owner 333 NORTH SAM HOUSTON PARKWAY EAST, SUITE 600, HOUSTON TX 77060
Robert Wesolek officer: Chief Financial Officer
Mark E. Stevenson director, officer: Secretary 8225 SAN DIEGO ST., ODESSA TX 79765
Eric C Prim director 4901 POLO PARKWAY, MIDLAND TX 79705
Grant M Petersen officer: Chief Executive Officer 1027 DAVIE ST., SUITE 482, VANCOUVER A1 V4E 1N9
Holloman Corp other: Affiliate 5257 WEST INTERSTATE 20, PO BOX 69410, ODESSA TX 79769
Holloman Oil & Gas Ltd. 10 percent owner 88 FORREST STREET, UNITS 8-9, COTTESLOE C3 6011
David R Lewis director 11115 EAST MONTGOMERY DRIVE, SUITE G, SPOKANE VALLEY WA 99206